{
    "nctId": "NCT00477100",
    "briefTitle": "Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer",
    "officialTitle": "Inflammatory Breast Cancer (IBC) Registry",
    "overallStatus": "RECRUITING",
    "conditions": "Inflammatory Breast Carcinoma, Invasive Breast Carcinoma, Second Primary Malignant Neoplasm",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1200,
    "primaryOutcomeMeasure": "Data, serum, tissue, peripheral blood mononuclear cells, and plasma sample collection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with clinical diagnosis of primary inflammatory breast cancer (IBC), second primary IBC, or highly suspicious for IBC (MD Anderson patients only).\n* Histological diagnosis of invasive breast cancer, or highly suspicious for IBC (MD Anderson patients only) but pending breast cancer diagnosis.\n* Be either newly diagnosed, or highly suspicious for IBC (MD Anderson patients only) \\[Cohort I\\] or have paraffin blocks or up to 20 unstained slides of each representative block(s) from the time of initial diagnosis of IBC(i.e. core biopsy and punch biopsy) and/or from mastectomy (Cohort II-MD Anderson patients only)\n* Age \\> 18 years\n* Able to provide informed consent\n\nExclusion Criteria:",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}